Keros Therapeutics, Inc. · NASDAQ:KROS

Tang Capital Management LLC reported a 7.90% stake in Keros Therapeutics, Inc. (Schedule 13G)

Event Oct 15, 2025 · Filed Oct 22, 2025

Tang Capital Management LLC reported a 7.90% stake in Keros Therapeutics, Inc., 2,418,984 shares, as a passive investor on Oct 15, 2025. Filed Oct 22, 2025 (Schedule 13G).

Stake
7.90%
Shares
2,418,984
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
TANG CAPITAL MANAGEMENT, LLC7.90%2,418,984
KEVIN TANG7.90%2,418,984
TANG CAPITAL PARTNERS, LP5.20%1,579,237
TANG CAPITAL PARTNERS INTERNATIONAL, LP2.70%839,747
TANG CAPITAL PARTNERS III, INC0%0
TANG CAPITAL PARTNERS IV, INC0%0

Source

View original at SEC

Related